Ondansetron is a generic medication available as a regular tablet, an orally disintegrating tablet, and an oral solution.
Ondansetron dosing varies depending on its intended use. An example dosage regimen may be 8 mg taken orally before chemotherapy, followed by 8 mg 8 hours after the first dose, and then 8 mg twice daily for 1–2 days.
The maximum dose of oral ondansetron is 24 mg per day.
How much ondansetron should I take? Quick reference |
|||
|---|---|---|---|
| Patient | Typical starting dose | Standard dosage | Maximum dose |
| Adults undergoing moderately emetogenic chemotherapy | 8 mg given 30 minutes before chemotherapy, followed by an 8 mg dose 8 hours after the first dose | 8 mg every 12 hours for 1–2 days following the completion of chemotherapy | 24 mg/day |
| Adults undergoing single high-dose radiation treatment to the abdomen | 8 mg given 1–2 hours before radiation treatment | 8 mg given every 8 hours after the first dose for 1–2 days after completing radiation | 24 mg/day |
| Adults undergoing surgery | 16 mg single oral dose given 1 hour before anesthesia | — | 16 mg |
The dosages listed are general guidelines; your healthcare provider may adjust your dose based on individual health factors.
Ondansetron is a prescription drug FDA-approved to prevent nausea and vomiting in people undergoing chemotherapy, radiation therapy, or surgery. It works as a 5-HT3 receptor antagonist, blocking serotonin in the brain and gut to calm the vomiting reflex.
Doses are typically taken by mouth before chemotherapy or radiation and may continue for one to two days following the procedure. Oral doses can be taken with or without food.
Ondansetron is available in various dosage forms, including regular tablets, orally disintegrating tablets (ODTs), and oral solutions. In a hospital or outpatient clinic, ondansetron may be given as an injectable solution either intravenously (IV) or intramuscularly (IM).
Tablet: 4 mg, 8 mg, and 24 mg
Orally disintegrating tablet: 4 mg and 8 mg
Oral solution: 4 mg per 5 mL
Injectable solution: 2 mg per mL
Brand names of ondansetron include Zofran and Zofran ODT. However, it is currently available as a generic drug only.
Detailed ondansetron dosage chart for adults |
|
|---|---|
| Indication | Standard dosage |
| Highly emetogenic chemotherapy | Oral: Single 24-mg dose given 30 minutes before chemotherapy. |
| IV: 0.15 mg/kg (150 mcg/kg) delivered IV over 15 minutes, starting 30 minutes before chemotherapy. The dosage may be given up to 2 more times, with the subsequent doses administered 4 and 8 hours after the first dose. Maximum of 16 mg per dose. | |
| Moderately emetogenic chemotherapy | Oral: 8 mg given 30 minutes before chemotherapy. Then, 8 mg given 8 hours after the first dose. Then, 8 mg every 12 hours for 1–2 days following the completion of chemotherapy. |
| IV: 0.15 mg/kg (150 mcg/kg) delivered IV over 15 minutes, starting 30 minutes before chemotherapy. The dosage may be given up to 2 more times, with the subsequent doses administered 4 and 8 hours after the first dose. Maximum of 16 mg per dose. | |
| Total body irradiation | Oral: 8 mg single dose given 1–2 hours before each dose of radiation each day. |
| Single high-dose radiation to the abdomen | Oral: 8 mg given 1–2 hours before radiation treatment. Then, 8 mg every 8 hours after the first dose for 1–2 days following radiation treatment. |
| Daily fractionated radiation to the abdomen | Oral: 8 mg given 1–2 hours before radiation treatment. Then, 8 mg is administered every 8 hours after the first dose, daily, during the period of radiation treatment. |
| Postoperative nausea or vomiting | Oral: 16 mg single oral dose given 1 hour before anesthesia. |
| IV/IM: 4 mg single dose given immediately before anesthesia or after surgery. |
Detailed ondansetron dosage chart for children |
|
|---|---|
| Indication | Standard dosage |
| Moderately emetogenic chemotherapy in children 12–17 years of age | Oral: Initial dose of 8 mg given 30 minutes before chemotherapy. Then, a subsequent 8-mg dose given 8 hours later. Then, 8 mg every 12 hours for 1–2 days after completion of chemotherapy. |
| Moderately emetogenic chemotherapy in children 4–11 years of age | Oral: Initial dose of 4 mg given 30 minutes before chemotherapy. Then, 4 mg given 4 and 8 hours after the first dose. Then 4 mg 3 times daily for 1–2 days after completion of chemotherapy. |
| Emetogenic chemotherapy (any risk level) in children and infants 6 months and older | IV: 0.15 mg/kg per dose (maximum of 16 mg per dose) given over 15 minutes starting 30 minutes before chemotherapy. Dosage is repeated 4 and 8 hours after the first dose for a total of 3 doses per day. |
| Postoperative nausea and vomiting in children and infants 1 month to 12 years and more than 40 kg (~88 lbs) | IV: 4 mg given immediately before anesthesia or shortly after surgery. |
| Postoperative nausea and vomiting in children and infants 1 month to 12 years and 40 kg (~88 lbs) or less | IV: 0.1 mg/kg given immediately before anesthesia or shortly after surgery. |
Ondansetron can be taken by mouth or given as an IV injection before chemotherapy for the prevention of nausea and vomiting. Some chemotherapy drugs, such as cisplatin, are considered highly emetogenic, meaning they often cause severe nausea and vomiting. In these cases, a single oral dose of 24 mg is administered 30 minutes before treatment. For chemotherapy that causes moderate nausea and vomiting, the typical oral regimen is 8 mg before chemotherapy, followed by 8 mg every eight hours for one to two days afterward.
Ondansetron is also FDA-approved for nausea and vomiting caused by radiation therapy, particularly when radiation is directed to the abdomen. Because much of the digestive system is located in this area, abdominal radiation often leads to nausea and vomiting. Radiation treatment to the abdomen can involve a single high dose of radiation, lower-dose fractions of radiation administered over several sessions, or total body irradiation before procedures like a bone marrow transplant.
For abdomen-only radiotherapy, a dose of 8 mg is given before the treatment. Ondansetron can then be taken in 8 mg doses every eight hours for one or two days after the procedure.
Total body irradiation is different. It typically requires two to three daily radiotherapy sessions, spread over three to four days. In such cases, ondansetron is administered as an 8 mg dose one to two hours before each radiotherapy session.
Ondansetron may be given if a surgeon expects nausea and vomiting as an adverse reaction to surgery. For prevention, the standard oral regimen consists of a single 16 mg dose administered one hour before anesthesia. Alternatively, an intravenous dose of 4 mg may be administered immediately before or after anesthesia, or at the conclusion of surgery.
Ondansetron is not used before all surgeries. It’s only used for those who have an increased risk of causing nausea and vomiting. For other surgeries, a person might wake up feeling nauseated or begin vomiting. In such cases, a healthcare professional may administer an ondansetron injection to alleviate symptoms quickly.
People with severe liver disease (hepatic impairment) may be restricted to a lower dose of 8 mg of ondansetron per day. People with kidney disease (renal impairment) or other medical conditions generally do not require a dosage adjustment.
Ondansetron is an effective antiemetic but may not be right for everyone.
Ondansetron has contraindications for people with known allergies to any of the drug’s ingredients. It should also be avoided in anyone receiving Apokyn (apomorphine), as this combination can cause sudden low blood pressure (hypotension) and loss of consciousness.
Other possible drug interactions include:
Antidepressants and other medicines that affect serotonin levels, such as SSRIs, SNRIs, and MAOIs
Medications that affect heart rhythm or can cause irregular heartbeats
Drugs that change how the liver breaks down ondansetron, such as phenytoin, carbamazepine, or rifampin
Ultram (tramadol), which may not work as well when taken with ondansetronOndansetron may cause serious problems, including:
Heart rhythm changes (QT interval prolongation), especially in individuals with heart failure, electrolyte imbalances, long QT syndrome, and those taking other medications that affect the heart.
Severe allergic reactions like rash, trouble breathing, or swelling of the face or throat
Serotonin syndrome, a reaction that can cause confusion, restlessness, fever, sweating, muscle stiffness, or seizures, especially if combined with certain antidepressants or pain medicines
Chest pain or tightness caused by reduced blood flow to the heart (rare, usually with IV use)
Masking of bowel blockage, since ondansetron may cover up symptoms like severe bloating, stomach pain, or not being able to pass gas
People with phenylketonuria (PKU) should avoid the orally disintegrating tablets because they contain aspartame.
Ondansetron is sometimes prescribed during pregnancy to treat severe morning sickness. While many healthcare providers consider it safe, some uncertainty remains due to the limited available clinical trials. Its safety during lactation or breastfeeding is not fully known.
Ondansetron can be taken orally as a regular tablet, an orally disintegrating tablet, or an oral solution. All oral formulations can be taken with or without food.
Take ondansetron tablets with a full glass of water.
Store tablets at room temperature (36°F to 86°F) in a light-resistant container.
Do not open the blister pack containing the tablet until you are ready to take it.
Do not push the tablet through the foil backing to remove it.
With dry hands, peel back the foil backing of one blister and gently remove the tablet.
Place the tablet on the tongue. Allow the tablet to dissolve fully. It will dissolve in seconds.
Swallow what’s left of the tablet with saliva.
Store ondansetron orally-disintegrating tablets in their original package at room temperature (36°F to 86°F).
Always use the calibrated oral syringe when measuring doses.
Ensure the bottles are kept upright and stored between 59°F and 86°F.
To protect the oral liquid form from light exposure, keep the bottles inside their cartons.
Ondansetron typically begins to take effect within 30 minutes to an hour. It reaches peak levels in the blood at around one and a half hours after oral administration.
The half-life of an 8-mg tablet or IV dose of ondansetron is around three to four hours in adults. That means it can take the body up to 20 hours to completely clear a dose. It may take longer in older adults with decreased liver function.
When administered by IV, ondansetron is injected slowly to minimize the risk of adverse effects, such as dizziness, flushing, or headache. In adults, smaller doses (such as 4–8 mg) are typically administered over a period of two to five minutes. Higher doses, if used, are given by infusion over about 15 minutes.
If you miss a dose of ondansetron, take it as soon as you remember unless it's almost time for the next dose. In that case, skip the missed pill and continue the regular dosing schedule. Do not take a double dose to make up for the missed one. If you're unsure what to do, consult your doctor or pharmacist for medical advice on managing additional doses.
Yes, it is possible to overdose on ondansetron. An ondansetron overdose can be a serious medical emergency that can cause blurred vision, constipation, low blood pressure, and fainting. Children who overdose on ondansetron are especially vulnerable to serotonin syndrome, a potentially dangerous condition that can cause drowsiness, rapid heart rate, increased sweating, and seizures. Seek immediate medical help if you suspect an overdose.
Zofran highlights of prescribing information, U.S. Food and Drug Administration (2025)
Common side effects from radiation therapy, Fox Chase Cancer Center (n.d.)
Total body irradiation for hematopoietic stem cell transplantation: what can we agree on?, Current Oncology (2021)
Ondansetron injection solution, DailyMed (2025)
Ondansetron use in pregnancy, Obstetrics & Gynecology (2021)
Ondansetron, StatPearls (2023)
Ondansetron clinical pharmacokinetics, Clinical Pharmacokinetics (1995)
Ondansetron, MedlinePlus (2024)
Gerardo Sison, Pharm.D., graduated from the University of Florida. He has worked in both community and hospital settings, providing drug information and medication therapy management services. As a medical writer, he hopes to educate and empower patients to better manage their health and navigate their treatment plans.
...Health education, drug info, wellness & more
Prescription savings vary by prescription and by pharmacy, and may reach up to 80% off cash price. This is a medical discount plan. This is NOT insurance. This program offers you the opportunity to locate providers of various types of medical services who will offer their services to you at discounted rates. The range of discounts for medical or ancillary services provided under the plan will vary depending on the type of provider and service received. You are fully responsible for paying for all health care services but will be entitled to receive a discount from those health care providers in accordance with the specific pre-negotiated discounted fee schedule. This program does not guarantee the quality of the services or procedures offered by the providers. Except for prescription drugs which you will pay directly to the pharmacy at the time of purchase, all other services received through a program provider will be charged to the credit card on file in your member account. The charge will include an administrative fee for use of the program. Towers Administrators LLC is the licensed discount medical plan organization with its administrative office located at 4510 Cox Road, Suite 111, Glen Allen, VA 23060. SingleCare Services, LLC is the marketer of the discount medical plan organization including its website, singlecare.com, with its corporate office located at 99 High Street, Suite 2800, Boston, MA 02110. For additional information, including an up-to-date list of providers, or assistance with any issue related to program membership, please contact member support any time at www.singlecare.com, or by calling toll-free 844-234-3057, 24 hours, 7 days a week (except major holidays). Pharmacy names, logos, brands, and other trademarks are the property of their respective owners.
Blog articles are not medical advice. They are intended for general informational purposes and are not meant to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. If you think you may have a medical emergency, immediately call your physician or dial 911.
© 2025 SingleCare Administrators. All rights reserved
© 2025 SingleCare Administrators. All rights reserved